Skip to main navigation Skip to search Skip to main content

Effects of nateglinide on DPP-IV activity and incretin hormone degradation in type 2 diabetic patients

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S367
JournalIRISH JOURNAL OF MEDICAL SCIENCE
Volume176
Publication statusPublished (in print/issue) - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this